[ad_1]
MS On (MS On) is one of these initiatives. It is part of the company's global #MSInsideOut campaign, which aims to better understand MS worldwide. MSOMM raises awareness of the emotional and multifaceted impact of MS on individuals and seeks out discoveries that can help find concrete solutions to meet the needs of patients and caregivers. People affected by multiple sclerosis were asked to complete the phrase "Multiple Sclerosis worries me when …" and, among these submissions, the main topics emerged among patients and caregivers, such as extreme fatigue, Unable to conduct and maintain physical activity and concerns for the future.
"Our society is deeply committed to MS and to a better understanding of the visible and invisible effects of the disease on patients," he said. Andrew Paterson, Global Head of Neurology and Immunology at Merck KGaA, Darmstadt, Germany. "We are inspired by the patients and caregivers who have advanced this understanding and made certain aspects of their MS visible by sharing their experience."
This year, World Multiple Sclerosis Day is the same week as the Consortium of Multiple Sclerosis Centers Consortium (MSAC) annual meeting. Seattle, WA. EMD Serono presents several paintings and murals developed by the creative director and the patient MSOMM Lydia Emily Archibald during a meeting. Lydia Emily used her talents to bring to life the unseen symptoms of MS with compelling illustrations. Her commitment and pbadion for advocacy continues to inspire and motivate the MS community.
"Although we all have different lives and responsibilities on a daily basis, we are affected in the same way by MS," Archibald said. "MS could strike in the form of frustration and struggle, but would elicit moments of sincere gratitude and accomplishment.All MSOMM submissions to date have been equally compelling and relatable.I am honored to have had the possibility of giving life to people's stories. "
Worldwide, Merck KGaA, Darmstadt, Germany Supports MSIF's informed decision making program by donating € 1 (up to € 50,000) for each publicly shared publication on social networks, including the combined use of hashtags #MSInsideOut and #MyInvisibleMS up to that June 8. The Informed Decision Making Program supports several MS patient group initiatives around the world that aim to provide reliable, accessible and up-to-date information so that people know that they are making the best decision for their lives. and their SP.
About multiple sclerosis
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system. It is the most common non-traumatic disabling neurological disease in young adults. It is estimated that more than 2.3 million people worldwide have MS. Although symptoms may vary, the most common symptoms of MS include blurred vision, numbness or tingling in limbs, and problems with strength and coordination. Recurrent forms of MS are the most common.
About World Multiple Sclerosis Day 2019
World Multiple Sclerosis Day is officially celebrated on May 30th of each year. Events and campaigns take place throughout the month of May. It brings together the global MS community to share stories, raise awareness and campaign with and for all people with multiple sclerosis. World Multiple Sclerosis Day 2019 will be held on May 30th. The 2019 campaign will call "My Invisible MS" (#MyInvisibleMS) and the theme is Visibility. In 2009, the International Federation of MS (MSF) and its members launched the first World MS Day. Together, we have joined hundreds of thousands of people around the world, with a campaign focused on a different theme each year. MSIF provides a free resource toolkit to help everyone participate in World MS Day. Anyone can use these tools or create their own tools to create positive changes in the lives of more than 2.3 million people worldwide.
EMD Serono, Inc. and Multiple Sclerosis
For over 20 years, EMD Serono has worked tirelessly to understand the journey of people living with MS to create a meaningful and positive experience for them and the broader MS community. However, there are still many unknowns about this complex and unpredictable disease. EMD Serono goes further to advance science.
About EMD Serono, Inc.
EMD Serono – the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the United States and Canada – is dedicated to the discovery, research and development of drugs for patients with hard-to-treat diseases. The company is committed to transforming lives by developing and offering meaningful solutions to meet the therapeutic and support needs of each patient. Building on a proven legacy and deep expertise in neurology, fertility and endocrinology, EMD Serono is developing potential new drugs in oncology and immuno-oncology while continuing to explore potential therapeutic options for therapeutics. diseases such as psoriasis, lupus and MS. Today, the company employs approximately 1,300 people in the country and carries out commercial, clinical and research activities in its home country. Mbadachusetts. www.emdserono.com
SOURCE EMD Serono
Related Links
www.emdserono.com
Source link
